The Food and Drug Administration will allow cosmetic drug and device maker Allergan Inc. to market its stomach-restricting Lap-Band to millions of new patients -- patients who are less obese than those currently using the device. Eve Troeh has more.
The Senate Judiciary Committee holds hearings today on how best to combat online piracy. We talk to the chairman of that committee, Sen. Patrick Leahy (D-Vt.) about the aggressive approach he would like to see.
Wednesday brought an end to the long-awaited deal between French pharmaceutical company Sanofi-Aventis and the U.S. biotech firm Genzyme. Sanofi will buy Genzyme for at least $20.1 billion. But the number could go higher if Genzym's drugs-in-development succeed when they go to market, as Eve Troeh explains.
The governing body that controls web domain names is preparing for what it calls a land rush. Soon, you might be seeing not just .com and .net but .eco, .flowers, .god, .gay, and dot just about anything else you can think of.
After a series of Toyota recalls, NASA -- that's right, the National Aeronautics and Space Administration -- is expected to publish its analysis of the so-called "runaway Toyotas" today. David Gura has more.